AN2 Therapeutics
pipeline targets high unmet needs in rare chronic and serious infectious diseases lung disease boron chemistry approach enables targeting of novel biological targets mid phase topline data japan attest as an therapeutics | AN2 Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2022
Slide
8 of 27
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
August 2022
pipeline targets high unmet needs in rare chronic and serious infectious diseases boron chemistry approach enables targeting of novel biological targets lung disease an therapeutics | AN2 Therapeutics
Related slides by other companies
9 Meters Biopharma
Investor Presentation
September 2022
pipeline one tract with multiple meaningful opportunities | 9 Meters Biopharma
Boundless Bio
IPO
March 2024
spyglass reveals cancer targets both novel and validated that intersect distinct nodes of | Boundless Bio
Exscientia
Investor Presentation
August 2023
why are our clinical candidates different | Exscientia
Exscientia
Investor Presentation
July 2023
why are our clinical candidates different | Exscientia
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io